CRNX
Price
$43.51
Change
-$2.40 (-5.23%)
Updated
Sep 29, 04:59 PM (EDT)
Capitalization
4.32B
38 days until earnings call
GPCR
Price
$24.81
Change
-$0.19 (-0.76%)
Updated
Sep 29, 02:07 PM (EDT)
Capitalization
1.44B
44 days until earnings call
Interact to see
Advertisement

CRNX vs GPCR

Header iconCRNX vs GPCR Comparison
Open Charts CRNX vs GPCRBanner chart's image
Crinetics Pharmaceuticals
Price$43.51
Change-$2.40 (-5.23%)
Volume$60.23K
Capitalization4.32B
Structure Therapeutics
Price$24.81
Change-$0.19 (-0.76%)
Volume$1.04K
Capitalization1.44B
CRNX vs GPCR Comparison Chart in %
Loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GPCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRNX vs. GPCR commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRNX is a Buy and GPCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (CRNX: $45.91 vs. GPCR: $25.00)
Brand notoriety: CRNX and GPCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRNX: 777% vs. GPCR: 86%
Market capitalization -- CRNX: $4.32B vs. GPCR: $1.44B
CRNX [@Biotechnology] is valued at $4.32B. GPCR’s [@Biotechnology] market capitalization is $1.44B. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRNX’s FA Score shows that 0 FA rating(s) are green whileGPCR’s FA Score has 1 green FA rating(s).

  • CRNX’s FA Score: 0 green, 5 red.
  • GPCR’s FA Score: 1 green, 4 red.
According to our system of comparison, both CRNX and GPCR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRNX’s TA Score shows that 6 TA indicator(s) are bullish while GPCR’s TA Score has 5 bullish TA indicator(s).

  • CRNX’s TA Score: 6 bullish, 4 bearish.
  • GPCR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CRNX is a better buy in the short-term than GPCR.

Price Growth

CRNX (@Biotechnology) experienced а +35.39% price change this week, while GPCR (@Biotechnology) price change was +6.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.29%. For the same industry, the average monthly price growth was +11.39%, and the average quarterly price growth was +59.66%.

Reported Earning Dates

CRNX is expected to report earnings on Nov 06, 2025.

GPCR is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+2.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($4.32B) has a higher market cap than GPCR($1.44B). GPCR YTD gains are higher at: -7.817 vs. CRNX (-10.209). GPCR has higher annual earnings (EBITDA): -218.56M vs. CRNX (-419.62M). CRNX has more cash in the bank: 1.2B vs. GPCR (786M). GPCR has less debt than CRNX: GPCR (7.68M) vs CRNX (49.9M). CRNX has higher revenues than GPCR: CRNX (1.39M) vs GPCR (0).
CRNXGPCRCRNX / GPCR
Capitalization4.32B1.44B300%
EBITDA-419.62M-218.56M192%
Gain YTD-10.209-7.817131%
P/E RatioN/AN/A-
Revenue1.39M0-
Total Cash1.2B786M152%
Total Debt49.9M7.68M650%
FUNDAMENTALS RATINGS
CRNX: Fundamental Ratings
CRNX
OUTLOOK RATING
1..100
36
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
50
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRNXGPCR
RSI
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
77%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
82%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
80%
Advances
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 8 days ago
85%
Declines
ODDS (%)
Bearish Trend 8 days ago
77%
Bearish Trend 19 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GPCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LSMIX14.390.16
+1.12%
Loomis Sayles Small/Mid Cap Growth Instl
USMIX22.150.23
+1.05%
Victory Extended Market Index
MWEIX48.830.32
+0.66%
MFS Global Equity I
PIOKX47.030.29
+0.62%
Victory Pioneer R6
FCGMX21.530.08
+0.37%
NYLI PineStone Global Equity Class R6

GPCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, GPCR has been loosely correlated with TERN. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if GPCR jumps, then TERN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GPCR
1D Price
Change %
GPCR100%
+0.04%
TERN - GPCR
44%
Loosely correlated
+2.69%
CLDX - GPCR
43%
Loosely correlated
+3.52%
ARWR - GPCR
43%
Loosely correlated
+3.60%
CRNX - GPCR
43%
Loosely correlated
+27.92%
OLMA - GPCR
41%
Loosely correlated
+16.12%
More